Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic control

Current Medicinal Chemistry

Volumn 18, Issue 32, 2011, Pages 4976-4986

  Angelone, T ^a,b   Quintieri, A M ^b   Amodio, N ^c   Cerra, M C ^a,b  

^a Departments of Cell Biology   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Chromogranin A; Gastrointestinal system; Ghrelin; Heart; Hypothalamus; Natriuretic peptides; Neuropeptide Y

Indexed keywords

APPETITE STIMULANT; CHROMOGRANIN A; GHRELIN; NATRIURETIC PEPTIDE RECEPTOR A; NEUROPEPTIDE Y; SIGNAL PEPTIDE;

APPETITE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; ENDOCRINE SYSTEM; FEEDING; FOOD INTAKE; GASTROINTESTINAL TRACT FUNCTION; HEART; HUMAN; HYPOTHALAMUS; MEDICAL LITERATURE; METABOLISM; MOLECULE; NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITION; SATIETY;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; ENDOCRINE SYSTEM; GASTROINTESTINAL TRACT; GHRELIN; HUMANS; HYPOTHALAMUS; NATRIURETIC PEPTIDES; NEUROPEPTIDE Y; NEUROSECRETORY SYSTEMS;

EID: 80054874394     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797535236     Document Type: Article

References (155)

1. Szczepaska-Sadowska, E. Neuropeptides in neurogenic disorders of the cardiovascular control. J. Physiol. Pharmacol., 2006, 11, 31-53
2. Weiler, R.; Marksteiner, J.; Bellmann, R.; Wohlfarter, T.; Schober, M.; Fischer-Colbrie, R.; Sperk, G.; Winkler, H. Chromogranins in rat brain: Characterization, topographical distribution and regulation of synthesis. Brain Res., 1990, 532, 87-94 (Pubitemid 20384644)
3. Tota, B.; Angelone, T.; Mazza, R.; Cerra, M.C. The chromogranin A-derived vasostatins: New players in the endocrine heart. Curr. Med. Chem., 2008, 15, 1444-1451 (Pubitemid 351997794)
4. De Wardener, H.E. The hypothalamus and hypertension. Physiol. Rev., 2001, 81, 1599-1658 (Pubitemid 32947779)
5. Jankowski, M.; Reis, A.M.; Wang, D.; Gutkowska, J. Postnatal ontogeny of natriuretic peptide systems in the rat hypothalamus. Brain Res. Dev. Brain Res., 2004, 152, 39-46 (Pubitemid 38993286)
6. Gower, W.R. Jr.; Dietz,J.R.; McCuen, R.W.; Fabri, P.J.; Lerner, E.A.; Schubert, M.L. Regulation of atrial natriuretic peptide secretion by cholinergic and PACAP neurons of the gastric antrum. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 284, G68-74 (Pubitemid 36076251)
7. Gower, W.R. Jr.; McCuen, R.W.; Arimura, A.; Coy, D.A.; Dietz, J.R.; Landon, C.S.; Schubert, M.L. Reciprocal paracrine pathways link atrial natriuretic peptide and somatostatin secretion in the antrum of the stomach. Regul. Pept., 2003, 110, 101-106 (Pubitemid 36078343)
8. Ogawa, T.; Vatta, M.; Bruneau, B.G.; de Bold, A.J. Characterization of natriuretic peptide production by adult heart atria. Am. J.Physiol., 1999, 276, H1977-1986 (Pubitemid 29323482)
9. Mantymaa, P.; Vuolteenaho, O.; Marttila, M.; Ruskoaho, H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinol., 1993, 133, 1470-1473 (Pubitemid 23267809)
10. Su, X.; Brower, G.; Janicki, J.S.; Chen, Y.F.; Oparil, S.; Dell'Italia, L.J. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J. Mol. Cell. Cardiol., 1999, 31, 1927-1936 (Pubitemid 29458709)
11. Dietz, J.R. Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc. Res., 2005, 68, 8-17 (Pubitemid 41268613)
12. Suga, S.; Nakao, K.; Hosoda, K.; Mukoyama, M.; Ogawa, Y.; Shirakami, G.; Arai, H.; Saito, Y.; Kambayashi, Y.; Inouye, K.; Imura, H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". Endocrinology, 1992, 130, 229-239
13. Horio, T.; Tokudome, T.; Maki, T.; Yoshihara, F.; Suga, S.; Nishikimi, T.; Kojima, M.; Kawano, Y.; Kangawa, K. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology, 2003, 144, 2279-2284 (Pubitemid 36629878)
14. Schweitz, H.; Vigne, P.; Moinier, D.; Frelin, C.H.; Lazdunski, M.J. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). Biol. Chem., 1992, 267, 13928-13932
15. Langub, M.C. Jr.; Dolgas, C.M. ; Watson, R.E. Jr.; Herman, J.P. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J. Neuroendocrinol., 1995, 7, 305-309
16. Herman, J.P.; Langub, M.C. Jr.; Watson, R.E. Jr. Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology, 1993, 133, 1903-1906 (Pubitemid 23295225)
17. Abdelalim, E.M.; Takada, T.; Torii, R.; Tooyama, I. Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey. Peptides, 2006, 27, 1886-1893 (Pubitemid 43866269)
18. Lauand, F.; Ruginsk, S.G.; Rodrigues, H.L.; Reis, W.L.; de Castro, M.; Elias, L.L.; Antunes-Rodrigues, J. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation. Neuroscience, 2007, 147, 247-257 (Pubitemid 46876701)
19. Li, L.; Zhang, L.K.; Pang, Y.Z.; Pan, C.S.; Qi, Y.F.; Chen, L.; Wang, X.; Tang, C.S.; Zhang J. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin., 2006, 27, 527-535
20. Gower Jr. W.R.; Salhab, K.F.; Fous, N.L.; Pillai, N.; Bundy, J.R.; Vesely, D.L.; Fabri, P.J.; Dietz, Jr. Regulation of atrial natriuretic peptide gene expression in gastric antrum by fasting. Am J Physiol Regul Integr. Comp. Physiol., 2000, 278, R770-780 (Pubitemid 30158140)
21. Sharkey, K.A.; Gall, D.G.; MacNaughton, W.K. Distribution and function of brain natriuretic peptide in the stomach and small intestine of the rat. Regul. Pept., 1991, 34, 61-70
22. Cerra, M.C.; Pellegrino, D. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Current Medicinal Chemistry, 2007, 14, 1-23
23. McGrath, M.F.; de Bold, M.L.; de Bold, A.J. The endocrine function of the heart. Trends Endocrinol. Metab., 2005, 16, 469-477 (Pubitemid 41660863)
24. Nussenzveig, D.R.; Lewicki, J.A.; Maack, T. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J. Biol. Chem., 1990, 265, 20952-20958 (Pubitemid 120014103)
25. Matsukawa, N.; Grzesik, W.J.; Takahashi, N.; Pandey, K.N.; Pang, S.; Yamauchi, M.; Smithies, O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. USA, 1999, 96, 7403-7408 (Pubitemid 29299674)
26. Sabbatini, M.E.; Rodriguez, M.R.; Di Carlo, M.B.; Davio, C.A.; Vatta, M.S.; Bianciotti, L.G. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: Role of vagal afferent and efferent pathways. Am J Physiol. Gastrointest. Liver Physiol., 2007, 293, G987-994
27. Ventimiglia, M.S; Rodriguez, M.R.; Elverdín, J.C.; Davio, C.A.; Vatta, M.S.; Bianciotti, L.G. Atrial natriuretic factor intracellular signaling in the rat submandibular gland. Regul. Pept., 2008, 150, 43-49
28. Anand-Srivastava, M.B.; Cantin, M. Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytes. Biochem. Biophys. Res. Commun., 1986, 138, 427-436 (Pubitemid 16053468)
29. Murthy, K.S.; Teng, B.Q.; Zhou, H.; Jin, J.C.; Grider, J.R.; Makhlouf, G.M. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am. J. Physiol. Gastrointest. Liver Physiol., 2000, 278, G974-980 (Pubitemid 30439177)
30. Palaparti, A.; Li, Y.; Anand-Srivastava, M.B. Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-Creceptor-mediated inhibition of adenylyl cyclase. Biochem J. 2000, 346, 313-320 (Pubitemid 30148115)
31. Koller, K.J.; Goeddel, D.V. Molecular biology of the natriuretic peptides and their receptors. Circ., 1992, 86, 1081-1088
32. Lin, X.; Hanze, J.; Heese, F.; Sodmann, R.; Lang, R.E. Gene expression of natriuretic peptide receptors in myocardial cells. Circ. Res., 1995, 77, 750-758
33. Kim, S.Z.; Cho, K.W.; Kim, S.H. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy. Am. J. Physiol., 1999, 277, H2280-2289 (Pubitemid 30048148)
34. Brown, L.A.; Nunez, D.J.; Wilkins, M.R. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J. Clin. Invest., 1993, 92, 2702-2712 (Pubitemid 24006535)
35. Kuhn, M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ. Res, 2003, 93, 700-709 (Pubitemid 37288664)
36. Dessi-Fulgheri, P.; Sarzani, R.; Tamburrini, P.; Moraca, A.; Espinosa, E.; Cola, G.; Giantomassi, L.; Rappelli, A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J. Hypertens., 1997, 15, 1695-1699 (Pubitemid 28029666)
37. Andreassi, M.G.; Del Ry, S.; Palmieri, C.; Clerico, A.; Biagini, A.; Giannessi, D. Up-regulation of 'clearance' receptors in patients with chronic heart failure: A possible explanation for the resistance to biological effects of cardiac natriuretic hormones. Eur. J. Heart Fail., 2001, 3, 407-414 (Pubitemid 32780524)
38. Wiedemann, K.; Jahn, H.; Kellner, M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp. Clin. Endocrinol. Diabetes, 2000, 108, 5-13 (Pubitemid 30160429)
39. Konrad, E.M.; Thibault, G.; Schiffrin, E.L.; Cantin, M. Atrial natriuretic factor receptor subtypes in the rat central nervous system. Hypertension, 1991, 17, 1144-1151
40. Vatta, M.S.; Rodríguez-Fermepín, M.; Durante, G.; Bianciotti, L.G.; Fernández, B.E. Atrial natriuretic factor inhibits norepinephrine biosynthesis and turnover in the rat hypothalamus. Regul. Pept., 1999, 85, 101-107 (Pubitemid 29525587)
41. Woodard, G.E.; Zhao, J.; Rosado,JA.; Brown, J. Differences between natriuretic peptide receptors in the olfactory bulb and hypothalamus from spontaneously hypertensive and normotensive rat brain. Neurosci. Res., 2003, 47, 421-429 (Pubitemid 37433834)
42. Crane, M.R.; O'Hanley, P.; Waldman, S.A. Rat intestinal cell atrial natriuretic peptide receptor coupled to guanylate cyclase. Gastroenterology, 1990, 99, 125-131 (Pubitemid 20202500)
43. Heimeier, R.A.; Donald, J.A. Renal C-type natriuretic peptide and natriuretic peptide receptor B mRNA expression are affected by water deprivation in the Spinifex Hopping mouse. Comp. Biochem. Physiol. A. Mol. Integr. Physiol., 2003, 13, 565-575 (Pubitemid 37412387)
44. Sabbatini, M.E. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Regul. Pept., 2009, 154, 5-15
45. Gower, W.R. Jr.; Carter, G.M.; McAfee, Q.; Solivan, S.M. Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells. Mol. Cell. Biochem., 2006, 293, 103-118 (Pubitemid 44843006)
46. Sarzani, R.; Paci, V.M.; Zingaretti, C.M.; Pierleoni, C.; Cinti, S.; Cola, G.; Rappelli, A.; Dessi-Fulgheri, P. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J. Hypertens., 1995, 13, 1241-1246 (Pubitemid 26003260)
47. Lonardo, G.; Cerbai, E.; Casini, S.; Giunti, G.; Bonacchi, M.; Battaglia, F.; Fiorani, B.; Stefano, P.L.; Sani, G.; Mugelli, A. Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes. Cardiovasc. Res., 2004, 63, 528-536 (Pubitemid 38970197)
48. Ohte, N.; Cheng, C.P.; Suzuki, M.; Little, W.C. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. J. Pharmacol. Exp. Ther., 1999, 291, 589-595 (Pubitemid 29503529)
49. Hirose, M.; Furukawa, Y.; Kurogouchi, F.; Nakajima, K.; Miyashita, Y.; Chiba, S. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. J. Pharmacol. Exp. Ther., 1998, 286, 70-76 (Pubitemid 28317975)
50. Zhang, Q.; Moalem, J.; Tse, J.; Scholz, P.M.; Weiss, H.R. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Eur. J. Pharmacol., 2005, 510, 209-215 (Pubitemid 40349199)
51. Gyurko, R.; Kuhlencordt, P.; Fishman, M.C.; Huang, P.L. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am. J. Physiol. Heart Circ. Physiol., 2000, 278, H971-981 (Pubitemid 30152555)
52. Herring N.; Lokale, M.N.; Danson, E.J.; Heaton, D.A.; Paterson, D.J. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J. Mol. Cell Cardiol., 2008, 44, 477-485 (Pubitemid 351374699)
53. Nishikimi, T.; Maeda, N.; Matsuoka, H. The role of natriuretic peptides in cardioprotection. Cardiovasc. Res., 2006, 69, 318-328 (Pubitemid 43098788)
54. Takagi, G.; Kiuchi, K.; Endo, T.; Yamamoto, T.; Sato, N.; Nejima, J.; Takano, T. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J. Cardiovasc. Pharmacol., 2000, 36, 22-30 (Pubitemid 30419118)
55. Rose, R.A.; Lomax, A.E.; Giles, W.R. Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: An NPR-C-mediated effect. Am. J. Physiol. Heart Circ. Physiol., 2003, 285, H2454-2462. (Pubitemid 37443062)
56. Kiemer, A.K.; Furst, R.; Vollmar, A.M. Vasoprotective actions of the atrial natriuretic peptide. Curr. Med. Chem. Cardiovasc. Hematol. Agents., 2005, 3, 11-21 (Pubitemid 40057727)
57. Zellner, C.; Protter, A.A.; Ko, E.; Pothireddy, M.R.; DeMarco, T.; Hutchison, S.J.; Chou, T.M.; Chatterjee, K.; Sudhir, K. Coronary vasodilator effects of BNP: Mechanisms of action in coronary conductance and resistance arteries. Am. J. Physiol. Heart Circ. Physiol., 1999, 276, H1049-1057 (Pubitemid 29157480)
58. Sabbatini, M.E.; Vatta, M.S.; Vescina, C.; Gonzales, S.; Fernandez, B.; Bianciotti, L.G. NPR-C receptors are involved in C-type natriuretic peptide response on bile secretion. Regul. Pept., 2003, 116, 13-20 (Pubitemid 37352910)
59. Sabbatini, M.E.; Vatta, M.S.; Vescina, C.; Castro, J.L.; Fernández B.E.; Bianciotti, L.G. Bile secretion is centrally regulated by C-type natriuretic peptide. Cell. Mol. Neurobiol., 2002, 22, 755-770 (Pubitemid 36169222)
60. Sabbatini, M.E.; Rodríguez, M.R.; Corbo, N.S.; Vatta, M.S.; Bianciotti, L.G. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway. Eur. J. Pharmacol., 2005, 524, 67-74 (Pubitemid 41606815)
61. Guo, H.S.; Cai, Z.X.; Wu, T.H.; Xu, J.; Qiu, Y.; Xu, W.X. Acta Pharmacol. Sin., 2007, 28, 1797-1802
62. Oliveira, M.H.; Antunes-Rodrigues, J.; Gutkowska, J.; Leal, A.; Elias, L.L.; Moreira, A.C. Atrial natriuretic peptide and feeding activity patterns in rats. Braz. J. Med. Biol. Res., 1997, 30, 465-469 (Pubitemid 127518291)
63. Moro, C.; Smith, S.R. Natriuretic peptides: New players in energy homeostasis. Diabetes, 2009, 58, 2726-2728
64. Miyashita, K.; Itoh, H.; Tsujimoto, H.; Tamura, N.; Fukunaga, Y.; Sone, M.; Yamahara, K.; Taura, D.; Inuzuka, M.; Sonoyama, T.; Nakao, K. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes., 2009, 58, 2880-2892
65. Glattard, E.; Angelone, T.; Strub, J.M.; Corti, A.; Aunis, D.; Tota, B.; Metz-Boutigue, M.H.; Goumon, Y. Characterization of natural vasostatincontaining peptides in rat heart. FEBS J., 2006, 273, 3311-3321 (Pubitemid 43990934)
66. Pieroni, M.; Corti, A.; Tota, B.; Curnis, F.; Angelone, T.; Colombo, B.; Cerra, M.C.; Bellocci, F.; Crea, F.; Maseri, A. Myocardial production of chromogranin A in human heart: A new regulatory peptide of cardiac function. Eur. Heart J., 2007, 28, 1117-1127 (Pubitemid 47343865)
67. Steiner, H.J.; Weiler, R.; Ludescher, C.; Schmid, K.W.; Winkler, H. Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J. Histochem. Cytochem., 1990, 38, 845-850 (Pubitemid 20177852)
68. Portela-Gomes, G.M.; Stridsberg, M. Chromogranin A in the human gastrointestinal tract: An immunocytochemical study with region-specific antibody. J. Histochem. Cytochem., 2002, 50,1487-92. (Pubitemid 36024896)
69. Helle, K.B.; Corti, A.;Metz-Boutigue, M.H.; Tota,B. The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties. Cell.Mol.Life Sci., 2007, 64, 2863-2886 (Pubitemid 351152248)
70. Angelone, T.; Quintieri, A.M.; Brar, B.K.; Limchaiyawat, P.T.; Tota, B.; Mahata, S.K.; Cerra, M.C. The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism. Endocrinol., 2008, 149, 4780-4793
71. González-Yanes, C.; Sánchez-Margalet, V. Pancreastatin modulates insulin signaling in rat adipocytes: Mechanisms of cross-talk. Diabetes, 2000, 49, 1288-94 (Pubitemid 30624227)
72. Koeslag, J.H.; Saunders,P.T.; Wessels, J.A. The chromogranins and the counter-regulatory hormones: Do they make homeostatic sense?. J.Physiol., 1999, 517, 643-649 (Pubitemid 29306452)
73. Weiergraber, M.; Pereverzev, A.; Vajna, R.; Henry, M.; Schramm, M.; Nastainczyk, W.; Grabsch, H.; Schneider, T. Immunodetection of alpha1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney. J. Histochem. Cytochem., 2000, 48, 807-819 (Pubitemid 30366615)
74. Estensen, M.E.; Hognestad, A.; Syversen, U.; Squire, I.; Ng, L.; Kjekshus, J.; Dickstein, K.; Omland, T. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. Am. Heart J., 2006, 152, 927. e1-6
75. Jansson, A.M.; Røsjø, H.; Omland, T.; Karlsson, T.; Hartford, M.; Flyvbjerg, A.; Caidahl, K. Prognostic value of circulating chromogranin A levels in acute coronary syndromes. Eur. Heart J., 2009, 30, 25-32
76. O'Connor, D.T.; Kailasam, M.T.; Kennedy, B.P.; Ziegler, M.G.; Yanaihara, N.; Parmer, R.J. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J. Hypertens, 2002, 20,1335-1343
77. Cerra, M.C.; De Iuri, L.; Angelone, T.; Corti, A.; Tota, B. Recombinant Nterminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res. Cardiol., 2006, 101, 43-52 (Pubitemid 43323431)
78. Cerra, M.C.; Gallo, M.P.; Angelone, T.; Quintieri, A.M.; Pulerá, E.; Filice, E.; Guérold, B.; Shooshtarizadeh, P.; Levi, R.; Ramella, R.; Brero, A.; Boero, O.; Metz-Boutigue, M.H.; Tota, B.; Alloatti, G. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. Faseb J., 2008, 22, 3992-4004
79. Cappello, S.; Angelone, T.; Tota, B.; Pagliaro, P.; Penna, C.; Rastaldo, R.; Corti, A.; Losano, G.; Cerra, M.C. Human recombinant chromogranin Aderived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Am. J. Physiol. Heart Circ. Physiol., 2007, 293, H719-H727 (Pubitemid 47105134)
80. Amato, A.; Serio, R.; Mulé, F. Relaxation induced by N-terminal fragments of chromogranin A in mouse gastric preparations. Regul. Pept., 2007, 139, 90-95 (Pubitemid 46216483)
81. Ghia, J.E.; Pradaud, I.; Crenner, F.; Metz-Boutique, M.H.; Aunis, D.; Angel, F. Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A. Regul. Pept., 2005, 124, 27-35 (Pubitemid 39488338)
82. Amato, A.; Corti, A.; Serio, R.; Mulé, F. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon. Regul. Pept., 2005, 130, 42-47 (Pubitemid 40966021)
83. El-Salhy, M.; Danielsson, A.; Stenling, R.; Grimelius, L. Colonic endocrine cells in inflammatory bowel disease. J. Intern. Med.,1997, 242, 413-419 (Pubitemid 27513108)
84. Tatemoto, K.; Efendic, S.; Mutt, V.; Makk, G.; Feistner, G.J.; Barchas, J.D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature, 1986, 324, 476-478 (Pubitemid 17184167)
85. Efendic, S.; Tatemoto, K.; Mutt, V.; Quan, C.; Chang, D.; Ostenson, C.G. Pancreastatin and islet hormone release. Proc. Natl. Acad. Sci. USA, 1987, 84,7257-7260 (Pubitemid 18017332)
86. Sánchez-Margalet, V.; Calvo, J.R.; Goberna, R. Glycogenolytic effect of pancreastatin in the rat. Biosci. Rep., 1990, 10, 87-91 (Pubitemid 20140882)
87. Sánchez-Margalet, V.; Calvo, J.R.; Goberna, R. Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo. Horm. Metab. Res., 1992, 24, 455-457
88. Sánchez-Margalet, V.; Goberna, R. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul. Pept., 1994, 51, 215-220 (Pubitemid 24197397)
89. Gonzalez-Yanes, C.; Sanchez-Margalet, V. Pancreastatin, a chromogranin Aderived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes. Cell. Mol. Life Sci., 2003, 60, 2749-2756 (Pubitemid 38041374)
90. Miyasaka, K.; Funakoshi, A.; Kitani, K.; Tamamura, H.; Funakoshi, S.; Fujii, N. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Pancreastatin inhibits central vagal nerve stimulation. Gastroenterology, 1990, 99,1751-1756
91. Lewis, J.J.; Zdon, M.J.; Adrian, T.E.; Modlin, I.M. Pancreastatin: A novel peptide inhibitor of parietal cell secretion. Surgery, 1988, 104, 1031-1036 (Pubitemid 19011983)
92. Fasciotto, B.H.; Gorr, S.U.; DeFranco, D.J.; Levine, M.A.; Cohn, D.V. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology, 1989, 125, 1617-1622 (Pubitemid 19224019)
93. Sánchez-Margalet, V. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Diabetologia, 1999, 42, 317-325 (Pubitemid 29111438)
94. Funakoshi, A.; Tateishi, K.; Shinozaki, H.; Matsumoto, M.; Wakasugi, H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulindependent diabetes mellitus (NIDDM). Regul. Pept., 1990, 30, 159-164 (Pubitemid 20276588)
95. Konturek, S.J.; Konturek, J.W.; Pawlik, T; Brzowki, T. Brain-Gut axis and its role in the control of food intake. J. Physiol. Pharmacol., 2004, 55, 137-154 (Pubitemid 38450982)
96. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402, 656-660 (Pubitemid 129516334)
97. Rindi, G.; Torsello, A.; Locatelli, V.; Solcia, E. Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system. Exp. Biol. Med. (Maywood), 2004, 229, 1007-1016 (Pubitemid 39431080)
98. Stengel, A.; Keire, D.; Goebel, M.; Evilevitch, L.; Wiggins, B.; Taché, Y.; Reeve, J.R. The Rapid method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology, 2009,150, 5113-5118
99. Zhang, G.; Yin, X.; Qi, Y.; Pendyala, L.; Chen, J.; Hou, D.; Tang, C. Ghrelin and cardiovascular diseases. Curr. Cardiol Rev., 2010, 6, 62-70
100. Leite-Moreira, A.F.; Rocha-Sousa, A.; Henriques-Coelho T. Cardiac, skeletal, and smooth muscle regulation by ghrelin. Vitamins and Hormones, 2007, 77, 207-238
101. Papotti, M.; Ghé, C.; Cassoni, P.; et al. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clinical Endocrinol. Metab., 2000, 85, 3803-3807
102. Williams, D.L.; Cummings, D.E. Regulation of ghrelin in physiologic and pathophysiologic states. J. Nutr., 2005, 135, 1320-1325 (Pubitemid 40638357)
103. Nakazato, M.; Murakami, N.; Date, Y.; Kojima, M.; Matsuo, H.; Kangawa, K.; Matsukura, S. A role for ghrelin in the central regulation of feeding. Nature, 2001, 409, 194-198 (Pubitemid 32144284)
104. Cummings, D.E.; Purnell, J.Q.; Frayo, R.S.; Schmidova, K.; Wisse, B.E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001, 50, 1714-1719 (Pubitemid 33641587)
105. Hahn, T.M.; Breininger, J.F.; Baskin, D.G.; Schwartz, M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci., 1998, 1, 271-272 (Pubitemid 128652670)
106. Sakata, I.; Yamazaki, M.; Inoue, K.; Hayashi, Y.; Kangawa, K.; Sakai, T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett., 2003, 342, 183-186 (Pubitemid 36570348)
107. Burdyga, G.; Varro, A.; Dimaline, R.; Thompson, D.G.; Dockray, G.J. Ghrelin receptors in rat and human nodose ganglia: Putative role in regulating CB-1 and MCH receptor abundance. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290, G1289-1297 (Pubitemid 43788312)
108. Tschöp, M.; Smiley, D.L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature, 2000, 407, 908-913
109. Klok, M.D.; Jakobsdottir, S.; Drent, M.L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obes. Rev., 2007, 8, 21-34 (Pubitemid 44952832)
110. Katugampola, S.D.; Pallikaros, Z.; Davenport, A.P. 125I-His9.-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up-regulation of receptors with atherosclerosis. British J. Pharmacol. 2001, 134, 143-149 (Pubitemid 32835477)
111. Iantorno, M.; Chen, H.; Kim, J.A.; Tesauro, M.; Lauro, D.; Cardillo, C.; Quon, M.J.Ghrelin has novel vascular actions that mimic PI 3-kinasedependent actions of insulin to stimulate production of NO from endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E756-764 (Pubitemid 46411053)
112. Mizia-Stec, K.; Zahorska-Markiewicz, B.; Olszanecka-Glinianowicz, M.; Janowska, J.; Mucha, Z.; Holecki, M.; Gasiora, Z. Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment. Endokrynol Pol., 2008, 59, 207-211
113. Soares, J.B.; Rocha-Sousa, A.; Castro-Chaves, P.; Henriques-Coelho, T.; Leite-Moreira, A.F. Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides, 2006, 27, 1616-1623 (Pubitemid 43866262)
114. Nagaya, N.; Moriya, J.; Yasumura, Y.; Uematsu, M.; Ono, F.; Shimizu, W.; Ueno, K.; Kitakaze, M.; Miyatake, K.; Kangawa, K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation, 2004, 110, 3674-3679 (Pubitemid 39665256)
115. Nagaya, N.; Uematsu, M.; Kojima, M.; Ikeda, Y.; Yoshihara, F.; Shimizu, W.; Hosoda, H.; Hirota, Y.; Ishida, H.; Mori, H.; Kangawa, K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation, 2001, 104, 1430-1435 (Pubitemid 32880158)
116. Baldanzi, G.; Filigheddu, N.; Cutrupi, S.; Catapano, F.; Bonissoni, S.; Fubini, A.; Malan, D.; Baj, G.; Granata, R.; Broglio, F.; Papotti, M.; Surico, N.; Bussolino, F.; Isgaard, J.; Deghenghi, R.; Sinigaglia, F.; Prat, M.; Muccioli, G.; Ghigo, E.; Graziani, A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. Journal of Cell Biology, 2002, 159, 1029-1037 (Pubitemid 36055757)
117. Isgaard, J.; Johansson, I. Ghrelin and GHS on cardiovascular applications/functions. J. Endocrinol. Invest., 2005, 28, 838-842 (Pubitemid 43162843)
118. Xu, J.P.; Wang, H.X.; Wang, W.; Zhang, L.K.; Tang, C.S. Ghrelin improves disturbed myocardial energy metabolism in rats with heart failure induced by isoproterenol. J. Pept. Sci., 2010, 16, 392-402
119. Li, Ch.; Yang, Z.W.; Yin, Z.R.; Jin, Z.; Xing, D.; Piao, L.H.; Kim, Y.C.; Xu, W.X. Relationship between atrial natriuretic peptide-immunoreactive cells and microvessels in rat gastric mucosa. Acta Pharmacol. Sin., 2006, 27, 205-211 (Pubitemid 43171159)
120. Everitt, B.J.; Hökfelt, T.; Terenius, L.; Tatemoto, K.; Mutt, V.; Goldstein, M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience, 1984, 11, 443-462 (Pubitemid 14155718)
121. Chronwall, B.M.; DiMaggio, D.A.; Massari, V.J.; Pickel, V.M.; Ruggiero, D.A.; O'Donohue, T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience, 1985, 5, 1159-1181 (Pubitemid 15226674)
122. White, J.D.; Kershaw, M. Increased hypothalamic neuropeptide Y expression following food deprivation. Mol. Cell. Neurosci.,1990, 1, 41-48 (Pubitemid 120040332)
123. Sahu, A.; Kalra, P.S.; Kalra, S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Ynconcentrations in the paraventricular nucleus. Peptides, 1988, 9, 83-86 (Pubitemid 18070134)
124. Walker, P.; Grouzmann, E.; Burnier, M.; Waeber, B. The role of neuropeptide Y in cardiovascular regulation. Trends Pharmacol. Sci., 1991, 12, 111-115
125. Redrobe, J.P.; Dumont, Y.; StPierre, J.A.; Quirion, R. Multiple receptors for neuropeptide Y in the hippocampus: Putative roles in seizures and cognition. Brain Res., 1999, 848, 153-166 (Pubitemid 30001664)
126. Cox, H. M. The role of NPYand related peptides in the control of gastrointestinal function. In Biology of neuropeptide Y and related peptides (ed. W. F. Colmers & C. Wahlestedt), 1993, 273-313. Totowa, NJ: Humana Press.
127. Widdowson, P. S.; Upton, R.; Henderson, L.; Buckingham, R.; Wilson, S.; Williams, G. Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Res., 1997, 774, 1-10 (Pubitemid 28007876)
128. Larhammar, D.; Salaneck, E. Molecular evolution of NPY receptor subtypes. Neuropeptides, 2004, 38, 141-151 (Pubitemid 39158855)
129. Henry, M.; Ghibaudi, L.; Gao, J.; Hwa, J. Energy metabolic profile of mice after chronic activation of central NPYY1, Y2, or Y5 receptors. J. Obes. Res., 2005, 13, 36-47
130. Crick, S.J.; Anderson, R.H.; Ho, S.Y.; Sheppard, M.N. Localisation and quantitation of autonomic innervation in the porcine heart II: Endocardium, myocardium and epicardium. J. Anat., 1999, 195, 359-373 (Pubitemid 29520625)
131. Jacques, D.; Sader, S.; Perreault, C.; Fournier, A.; Pelletier, G.; Beck-Sickinger, A.G.; Descorbeth, M. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: Modulation of intracellular calcium. Can. J. Physiol. Pharmacol., 2003, 81, 288-300 (Pubitemid 36523652)
132. Stanley, B.G.; Leibowitz, S.F. Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci., 1984, 35, 2635-2642 (Pubitemid 15221101)
133. Dube, M.G.; Xu, B.; Crowley, W.R.; Kalra, P.S.; Kalra, S.P. Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res., 1994, 646, 341-344 (Pubitemid 24151777)
134. Shibasaki, T.; Oda, T.; Imaki, T.; Ling, N.; Demura, H. Injection of antineuropeptide-Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats. Brain Res., 1993, 601, 313-316 (Pubitemid 23047698)
135. Day,D.E.; Keen-Rhinehart, E.; Bartness, T.J. Role of NPY and its receptor subtypes in foraging, food hoarding, and food intake by Siberian hamsters. Am. J. Physiol., 2005, 289, R29-R36 (Pubitemid 40874955)
136. Hwa, J.J.; Witten, M.B.; Williams, P.; Ghibaudi, L.; Gao, J.; Salisbury, B.G.; Mullins, D.; Hamud, F.; Strader, C.D.; Parker, E.M. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am. J. Physiol., 1999, 277, R1428-434
137. Franco-Cereceda, A.; Liska, J. Neuropeptide Y Y1 receptors in vascular pharmacology. Eur. J. Pharmacol., 1998, 349, 1-14
138. Richardson, R.J.; Grkovic, I.; Allen, A.M.; Anderson, C.R. Separate neurochemical classes of sympathetic postganglionic neurons project to the left ventricle of the rat heart. Cell. Tissue Res., 2006, 324, 9-16 (Pubitemid 43320237)
139. Onuoha, G.N.; Nicholls, D.P.; Alpar, E.K.; Ritchie, A.; Shaw, C.; Buchanan, K. Regulatory peptides in the heart and major vessels of man and mammals. Neuropeptides, 1999, 33, 165-172 (Pubitemid 29254080)
140. Grundemar, L.; Jonas, S.E.; Mörner, N.; Högestätt, E.D.; Wahlestedt, C.; Hakanson, R. Characterization of vascular neuropeptide Y receptors. Br. J. Pharmacol., 1992, 105, 45-50
141. Zukowska-Grojec, Z.; Marks, E.S.; Haass, M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am. J. Physiol., 1987, 253, H1234-1239
142. Zukowska-Grojec, Z.; Karwatowska-Prokopczuk, E.; Fisher, T.A.; Ji, H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: Role of its inducible receptors. Regul. Pept., 1998, 75-76, 231-238 (Pubitemid 28477532)
143. Millar, B.C.; Schlüter, K.D.; Zhou, X.J.; McDermott, B.J.; Piper, H.M. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am. J. Physiol., 1994, 266, C1271-1277
144. Millar, B.C.; Weis, T.; Piper, H.M.; Weber, M.; Borchard, U.; McDermott, B.J.; Balasubramaniam, A. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am. J. Physiol., 1991, 261, H1727-1733
145. Nolan, P.D.; Batin, R.; Andrews, S.J.; Lindsay, P.; Brooksby and M. Mullen; et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart), Circulation, 1998, 98, 1510-1516
146. Bristow, M.R.; Krause-Steinrauf, H.; Nuzzo, R.; Liang, C.S.; Lindenfeld, J.; Lowes, B.D.; Hattler, B.; Abraham, W.T.; Olson, L.; Krueger, S.; Thaneemit-Chen, S.; Hare, J.M.; Loeb, H.S.; Domanski, M.J.; Eichhorn, E.J.; Zelis, R.; Lavori, P. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation, 2004, 110, 1437-1442 (Pubitemid 39242692)
147. Rasmusson, A.M.; Schnurr, P.P.; Zukowska, Z.; Scioli, E.; Forman, D.E. Adaptation to extreme stress: Post-traumatic stress disorder, neuropeptide Y and metabolic syndrome. Exp. Biol. Med. (Maywood), 2010, 235, 1150-1162
148. Vona-Davis, L.C.; McFadden, D.W. NPY family of hormones: Clinical relevance and potential use in gastrointestinal disease. Curr. Top Med. Chem., 2007, 7,1710-1720. (Pubitemid 350131008)
149. Ishiguchi, T.; Amano, T.; Matsubayashi, H.; Tada, H.; Fujita, M.; Takahashi, T. Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 281, R1522-1530
150. Forbes, S.; Tolhurst, R.; Ellis, M.; Herzog, H.; Bornstein, J.C.; Cox, H.M. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y(1) and Y(2) receptors. Br. J. Pharmacol., 2011, doi:10.1111/j.1476-5381.2011.01401
151. Cowley, M.A.; Smith, R.G.; Diano, S.; Tschöp, M.; Pronchuk, N.; Grove, K.L.; Strasburger, C.J.; Bidlingmaier, M.; Esterman, M.; Heiman, M.L.; Garcia-Segura, L.M.; Nillni, E.A.; Mendez, P.; Low, M.J.; Sotonyi, P.; Friedman, J.M.; Liu, H.; Pinto, S.; Colmers, W.F.; Cone, R.D.; Horvath, T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron., 2003, 37, 649-661 (Pubitemid 36262986)
152. Willesen, M.G.; Kristensen, P.; Romer, J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology, 1999, 70, 306-316
153. Toshinai, K.; Date, Y.; Murakami, N.; Shimada, M.; Mondal, M.S.; Shimbara, T.; Guan, J.L.; Wang, Q.P.; Funahashi, H.; Sakurai, T.; Shioda, S.; Matsukura, S.; Kangawa, K.; Nakazato, M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology, 2003, 144, 1506-1512 (Pubitemid 36428493)
154. St-Pierre, D.H.; Wang, L.; Taché Y. Ghrelin: A Novel Player in the Gut-Brain Regulation of Growth Hormone and Energy Balance. News. Physiol. Sci., 2003, 18, 242-246 (Pubitemid 38019372)
155. Barabási A.L. Network medicine-from obesity to the "diseasome". New Engl. J. Med., 2007, 357, 404-407